Scholarly Index

Brian I. Rini

Vanderbilt University; 75,857 total citations; 1,055 total publications; best world rank #4

Vanderbilt University

75,857Total citations

1,055Total publications

122H-index

Published ranking records

Field	Window	World rank	National rank	Impact score
Renal cell carcinoma treatment	Lifetime	5	US 5	99.93
Cancer Genomics and Diagnostics	Lifetime	25	US 18	99.92
Renal and related cancers	Lifetime	7	US 6	99.90
Cancer Immunotherapy and Biomarkers	Lifetime	29	US 18	99.91
Economic and Financial Impacts of Cancer	Lifetime	8	US 7	99.81
Ferroptosis and cancer prognosis	Lifetime	14	US 6	99.65
Pancreatic and Hepatic Oncology Research	Lifetime	53	US 35	99.78
COVID-19 and healthcare impacts	Lifetime	41	US 17	98.88
Cancer Diagnosis and Treatment	Lifetime	122	US 73	99.08
Cancer, Hypoxia, and Metabolism	Lifetime	281	US 139	99.16
Bladder and Urothelial Cancer Treatments	Lifetime	207	US 117	99.09
CAR-T cell therapy research	Lifetime	373	US 237	98.88
Multiple and Secondary Primary Cancers	Lifetime	146	US 61	98.26
Angiogenesis and VEGF in Cancer	Lifetime	285	US 131	98.18
Immunotherapy and Immune Responses	Lifetime	915	US 456	98.59
Tuberous Sclerosis Complex Research	Lifetime	79	US 48	96.11
Vascular Tumors and Angiosarcomas	Lifetime	380	US 199	95.42
Inflammatory Biomarkers in Disease Prognosis	Lifetime	860	US 130	89.19
Renal cell carcinoma treatment	2021-2025	5	US 4	99.85
Renal and related cancers	2021-2025	4	US 3	99.82
Cancer Genomics and Diagnostics	2021-2025	41	US 20	99.57
Cancer Immunotherapy and Biomarkers	2021-2025	148	US 60	99.45
Pancreatic and Hepatic Oncology Research	2021-2025	90	US 30	98.90
Economic and Financial Impacts of Cancer	2021-2025	46	US 26	97.95
COVID-19 and healthcare impacts	2021-2025	338	US 115	94.35
Bladder and Urothelial Cancer Treatments	2021-2025	365	US 116	95.68
Cancer, Hypoxia, and Metabolism	2021-2025	457	US 109	91.09
Inflammatory Biomarkers in Disease Prognosis	2021-2025	461	US 35	81.69